Medtronic has announced the first subject enrolment in the PELE trial, aiming to assess the Onyx liquid embolic system (LES).

The medical device industry faces being pulled into a broader contest over control, sovereignty and industrial self-sufficiency.

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Tempus AI’s ECG-Low (ejection fraction) EF software.

With the aim of being the largest life sector by 2035 behind only the US and China, the UK government is ramping up commercialisation.

Varian has introduced the next-generation microwave ablation solution, IntelliBlate, in Europe to treat soft tissue tumours.

Bio-Techne has announced a collaboration to distribute Spear Bio’s advanced SPEAR UltraDetect immunoassays globally.

BD has reached an agreement to merge its Biosciences & Diagnostic Solutions business with Waters Corporation in a nearly $17.5bn deal.

Viome, with Scripps Research, is set to develop and clinically validate the first RNA test for detecting precancerous colon polyps.

Medtronic has secured EU CE mark approval for LigaSure RAS, a vessel-sealing instrument for use with the company’s Hugo robotic-assisted surgery (RAS) system.

Zimmer Biomet has signed a definitive agreement to acquire orthopaedic robotics company Monogram Technologies.

Charlie Whelan, a Senior Director of Consulting at GlobalData, discusses the latest trends in medical devices for 2025.

The US FDA has cleared Intuitive's Vessel Sealer Curved for use with the company’s multiport da Vinci surgical systems.